Study guide

13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality

NCRA Oncology Data Specialist ODS-C

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters

1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish

2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws

2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority

3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance

3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance

4 Chapter 4: Registry Organization, Staffing & Information Systems

4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning

5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement

5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)

6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality

6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)

7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics

7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data

8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer

8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors

9 Chapter 9: Casefinding & Reportability

9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"

10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators

10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More

11 Chapter 11: Class of Case, Key Dates & Case Identifiers

11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them

12 Chapter 12: Follow-Up, Vital Status & Recurrence

12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary

13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade

13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables

14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules

14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules

15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018

15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples

16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS

16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation

13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality

Key Takeaways Explain This Topic AI

Topography codes are C plus three digits (for example C504 for the upper-outer quadrant of the breast); STORE says to record the site of origin and not to record the decimal point.

Subcategory 8 is for a single tumor that overlaps two or more subsites when the point of origin is unknown; subcategory 9 is for multiple tumors that start in different subsites of one organ, or when the subsite is unknown.

For breast, tumors at 12, 3, 6 or 9 o'clock are coded C508, and multiple tumors in different quadrants, inflammatory carcinoma, or tumor involving three-quarters or more of the breast are coded C509.

An occult head and neck primary found only in a neck node (2018+) is coded C760 if HPV and EBV are negative or not tested, C109 if p16-positive, and C119 if EBER-positive.

Laterality [410] is 0 not paired, 1 right, 2 left, 3 one side unspecified, 4 bilateral with unknown side of origin (single primary), 5 midline, or 9 paired site with no information; unknown primary (C809) is coded 0.

Last updated: September 2026

Structure of a topography code

ICD-O-3.2, which North American registries use for cases diagnosed in 2021 and later, has two axes: topography (site) and morphology (histology and behavior, Section 13.3). Topography codes come from the malignant neoplasm sections of ICD-10, but ICD-O uses them for all behaviors of a tumor at that site.

  • Part Example C50.4 Meaning
  • C + first two digits C50 Organ or region (breast)
  • Fourth character .4 Subsite (upper-outer quadrant)
  • .8 C50.8 Overlapping lesion
  • .9 C50.9 Site, NOS

STORE instructs registrars to record the code without the decimal point (C504).

STORE primary site instructions

Record the ICD-O topography code for the site of origin . A metastatic site is never the primary site; spread is captured in staging.

Consult the physician advisor to identify the primary site, or the most definitive site code, if the record does not say.

Follow ICD-O and the Solid Tumor Rules for solid tumors, and the Hematopoietic and Lymphoid Neoplasm Manual and Database for lymphomas, leukemias and other heme neoplasms.

Subcategory 8: a single tumor that overlaps the boundaries of two or more subsites, with the point of origin unknown.

Subcategory 9: multiple tumors that originate in different subsites of one organ. The .9 code is also used when the record does not identify the subsite.

  • Special site rules
  • Breast (Solid Tumor Rules, Table 1)
  • Description Code
  • Nipple, areola, or Paget disease with no underlying tumor C500
  • Central: subareolar, retroareolar, within 1 cm of the areolar complex C501
  • Upper inner / lower inner / upper outer / lower outer quadrant C502 / C503 / C504 / C505
  • Axillary tail (tail of Spence) C506

12, 3, 6 or 9 o'clock ; "upper breast," "inner breast" and other NOS halves; single tumor overlapping quadrants C508

Multiple tumors in different quadrants of the same breast; three-quarters or more of the breast involved; diffuse; inflammatory without a palpable mass; quadrant unknown C509

Paget disease with an underlying tumor is coded to the quadrant of the underlying tumor.

Head and neck

Occult cervical lymph node (2018+): when a neck node shows carcinoma and no head and neck primary is found:

C760 if the node was not tested for, or is negative for, both HPV and EBV. This uses the AJCC chapter on cervical nodes and unknown primary.

C109 if the node is p16-positive (HPV-mediated oropharyngeal schema).

C119 if the node is EBER-positive , or both EBER- and p16-positive (nasopharynx schema).

Cutaneous carcinoma of the head and neck: for a skin cancer overlapping head and neck sites, code the site where the bulk or epicenter is. Do not use C448, which is reserved for skin lesions overlapping head and neck and other body areas.

Colon and familial adenomatous polyposis

Under the colon Solid Tumor Rules, FAP with carcinoma is a single primary. Its site code is:

  • C189 when more than one colon segment is involved;
  • C199 when both the colon and the rectosigmoid or rectum are involved;

C260 when both the colon and the small intestine are involved.

Other sites

Kaposi sarcoma: code the site where it arises; use C449 (skin, NOS) if it arises in skin and another site at the same time, or if the primary site is not identified.

Lymphomas: code the involved lymph node region (C770–C779) or the extranodal organ, following the Hematopoietic manual. C77 is not used as a primary site for metastatic carcinoma.

Leukemias and plasma cell myeloma: C421 (bone marrow).

Unknown primary: C809 when the site of origin cannot be found after workup.

Ill-defined sites (C76): use them only when a more specific site cannot be assigned. For example, a sarcoma arising in the retroperitoneum is C480 , not C762.

Finding the subsite

Use the documents that describe where the tumor is : imaging, endoscopy (for example, distance from the anal verge), the operative report and the gross pathology description.

A procedure name only hints at the site. A "right hemicolectomy" removes the cecum, ascending colon and hepatic flexure, so code from the documented tumor location, not from the procedure.

Revising the diagnosis: STORE says to change the primary site, laterality, histology, grade and stage as information becomes more complete. There is no time limit for revisions that improve the original diagnosis, but staging must follow the time frame and criteria of the system used at diagnosis. Most revisions involve unknown primaries.

Laterality [410]

STORE requires laterality coded 1–5 or 9 for paired organs , such as the parotid gland, lung, pleura, breast, ovary, fallopian tube, testis, kidney, renal pelvis, ureter, eye, adrenal gland, the long bones of the limbs, and the skin, soft tissue and peripheral nerves of the limbs and trunk. Some CNS sites are also listed (cerebral meninges NOS and the cerebrum lobes).

  • Code Meaning
  • 0 Not a paired site (also used for unknown primary, C809)
  • 1 Origin of primary is right
  • 2 Origin of primary is left
  • 3 Only one side involved, right or left origin not specified

4 Bilateral involvement at diagnosis, side of origin unknown, single primary . Examples: both ovaries involved with a single histology; bilateral retinoblastoma; bilateral Wilms tumor; bilateral inflammatory breast carcinoma; diffuse bilateral lung nodules

  • 5 Paired site, midline tumor (for example, skin of the trunk; the breasts cannot have a midline tumor)
  • 9 Paired site, no laterality information; also used for death certificate only cases

Rules to remember:

Do not code metastatic spread to the other side as bilateral.

Non-paired sites may be coded right or left when appropriate; otherwise use 0.

Bilateral tumors are usually separate primaries (for example, the breast rules make bilateral breast cancers two primaries). Code 4 is used only when the rules make them a single primary.

Loading diagram... Choosing the fourth character